Glenn Goetgeluk

1.1k citations
17 papers · 539 indexed · h-index 13
Topics
CAR-T cell therapy research (10 papers)Immunotherapy and Immune Responses (7 papers)T-cell and B-cell Immunology (6 papers)

In The Last Decade

Glenn Goetgeluk

17 papers receiving 535 citations

Peers

Glenn Goetgeluk
Comparison fields: 5 of 63
  • Immunology 265
  • Oncology 250
  • Molecular Biology 185
  • Biomedical Engineering 153
  • Genetics 71
Replace Stijn De Munter with:
Stijn De Munter Belgium
Afshin Mashadi-Hossein United States
Tanmay Dichwalkar United States
Miryam Horovitz‐Fried Israel
Adam Drake United States
Vishaka Muhunthan United States
Sharyn Thomas United Kingdom
Iraklis C. Kourtis Switzerland
Shozo Ohtsuki United States
Glenn Goetgeluk relative to Stijn De Munter Belgium Stijn De Munter's profile →
Citations per field
00.5×
Stijn De Munter · 1×
Citations per year

Countries citing papers authored by Glenn Goetgeluk

Since Specialization
Citations

This map shows the geographic impact of Glenn Goetgeluk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Goetgeluk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Goetgeluk more than expected).

Fields of papers citing papers by Glenn Goetgeluk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Goetgeluk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Goetgeluk. The network helps show where Glenn Goetgeluk may publish in the future.

Co-authorship network of co-authors of Glenn Goetgeluk

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Goetgeluk. A scholar is included among the top collaborators of Glenn Goetgeluk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Goetgeluk. Glenn Goetgeluk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 4
2 15
3 17
4 26
5 6
6 43
7 57
8 8
9 28
10 5
11 65
12 55
13 101
14 37
15 23
16 20
17 29

About Glenn Goetgeluk

Glenn Goetgeluk is a scholar working on Immunology, Oncology and Genetics, having authored 17 papers that have together received 539 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Immunology (265 citations), Oncology (250 citations) and Biomedical Engineering (153 citations). Glenn Goetgeluk has collaborated with scholars based in Belgium, Netherlands and Germany. Frequent co-authors include Bart Vandekerckhove, Stijn De Munter, Karin Weening, Tessa Kerre, Sarah Bonte, Melissa Pille, David Vermijlen, Hinrich Abken, Tom Taghon and Stefaan C. De Smedt. Their work appears in journals such as Advanced Materials, The Journal of Experimental Medicine and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026